Loading...

Poxel S.A.

0RA2.L•LSE
Healthcare
Biotechnology
£1.60
£0.00(0.00%)

Poxel S.A. (0RA2.L) Stock Overview

Explore Poxel S.A.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B

Score: 63.9/100

Key Financials

Market Cap30.9M
P/E Ratio-1.50
EPS (TTM)$-0.83
ROE0.32%
Fundamental Analysis

AI Price Forecasts

1 WeekN/A
1 MonthN/A
3 MonthsN/A
1 Year TargetN/A

0RA2.L Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Poxel S.A. (0RA2.L) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of N/A.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -1.50 and a market capitalization of 30.9M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Frequently Asked Questions

;